EBS - Feds may need $7B to adequately respond to monkeypox outbreak - WaPo
- The Biden administration may require as much as $7B in order to deal with the current monkeypox outbreak in the country, according to a memo obtained by The Washington Post .
- The money would be used for monkeypox vaccines, treatments, and testing. It would also allow HHS to support monkeypox vaccine manufacturing in the U.S. Bavarian Nordic's ( OTCPK:BVNKF ) JYNNEOS shot is made in Denmark.
- The newspaper reported that White House aides recently brought up options on how to respond to monkeypox with Democrats on the Senate Committee on Health, Education, Labor & Pensions. However, a formal request for funding has yet to be made.
- The memo also calls for as much as $31B in additional funding to fight COVID-19.
- Monkeypox names: SIGA Technologies ( NASDAQ: SIGA ), Chimerix ( NASDAQ: CMRX ), and Emergent Biosolutions ( NYSE: EBS ).
- Bavarian Nordic is in discussions to boost production of JYNNEOS .
For further details see:
Feds may need $7B to adequately respond to monkeypox outbreak - WaPo